|
Volumn 40, Issue 5, 2001, Pages 558-565
|
Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOTHERAPY;
PATIENT TREATMENT;
RADIATION;
RADIOTHERAPY;
SURGERY;
TUMORS;
CANCER CONTROL;
ONCOLOGY;
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
VINBLASTINE;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
ESOPHAGUS CANCER;
ESOPHAGUS RESECTION;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
DOSE FRACTIONATION;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
PREOPERATIVE CARE;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VINBLASTINE;
|
EID: 0034799713
PISSN: 0284186X
EISSN: None
Source Type: Journal
DOI: 10.1080/028418601750444088 Document Type: Article |
Times cited : (9)
|
References (33)
|